Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support

Launched by FONDS DE DOTATION HTC PROJECT · Nov 22, 2023

Keywords

ClinConnect Summary

**Trial Summary: Evaluation of NewSpringForMe for Bone Marrow Transplant Patients**

This clinical trial is studying a new digital support tool called NewSpringForMe, designed to help patients undergoing bone marrow transplants for blood-related diseases. The goal of this tool is to improve the quality of life for these patients by providing personalized support in areas like mental health, nutrition, and physical activity. The trial will evaluate how effective NewSpringForMe is in helping patients feel better and recover successfully after their transplant.

To participate in this study, individuals must be at least 18 years old and be receiving their first bone marrow or stem cell transplant at St-Louis Hospital. They also need to be able to use a digital platform and understand the study's purpose. Participants will receive tailored recommendations and tools through NewSpringForMe, which will be integrated into their medical care from the beginning of their treatment and for years afterward. By taking part in this trial, patients will help researchers understand how comprehensive support can enhance healing and reduce complications after a transplant.

Gender

ALL

Eligibility criteria

• Inclusion criteria :
• • at least 18 years old
• • with a first indication for allograft bone marrow or Peripheric Stem Cells
• • monitored by the adult hematology transplant department St-Louis Hospital
• • having signed the consent
• • affiliated to a social security scheme
• • able to understand the objectives of the study and to use a digital tool
• Exclusion criteria :
• • aged under 18
• • with an indication of second or third allograft
• • not being affiliated to a social security scheme